Skip to main content

Table 2 Average daily doses of everolimus (mg/day) and mycophenolate mofetil (g/day) by visit window (safety population)

From: Efficacy and safety of concentration-controlled everolimus with reduced-dose cyclosporine in Japanese de novo renal transplant patients: 12-month results

 

Everolimus 1.5 mg (n= 61)

MMF (n= 61)

Visit window

n

Mean ± SD

n

Mean ± SD

Day 3

61

1.49 (0.0.048)

61

1.95 (0.194)

Day 7

60

1.70 (0.447)

61

1.88 (0.297)

Month 1

57

1.72 (0.539)

60

1.70 (0.475)

Month 3

55

1.70 (0.628)

58

1.33 (0.606)

Month 4

55

1.68 (0.611)

56

1.22 (0.595)

Month 6

55

1.65 (0.602)

55

1.28 (0.583)

Month 7

55

1.61 (0.610)

54

1.28 (0.570)

Month 9

54

1.68 (0.656)

54

1.25 (0.530)

Month 12

53

1.68 (0.705)

53

1.24 (0.530)

  1. MMF, mycophenolate mofetil; SD, standard deviation.